Sangamo BioSciences, Inc. researches and develops transcription factors in the regulation of genes.  These transcription factors are the proteins that turn genes on and off and regulate gene expression by recognizing specific DNA sequences.

S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

S-3 | Registration statement for specified transactions by certain issuers

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Sangamo Biosciences (SGMO US)

S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

S-3 | Registration statement for specified transactions by certain issuers

Current Report (Form 8-K | Period ending 2024-11-12)

Quarterly Report (Form 10-Q | Period ending 2024-09-30)

Current Report (Form 8-K | Period ending 2024-10-04)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)